Recombinant protein vaccination for antigen-specific cancer immunotherapy

2011 ◽  
pp. 87-102
Author(s):  
Pedro de Sousa Alves ◽  
Vincent Brichard
Keyword(s):  
Recombinant Protein ◽  
Cancer Immunotherapy ◽  
Specific Cancer

scholarly journals Tecemotide: An antigen-specific cancer immunotherapy

2014 ◽  
Vol 10 (11) ◽  
pp. 3383-3393 ◽  
Author(s):  
Gregory T Wurz ◽  
Chiao-Jung Kao ◽  
Michael Wolf ◽  
Michael W DeGregorio
Keyword(s):  
Cancer Immunotherapy ◽  
Specific Cancer

scholarly journals Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine

2000 ◽  
Vol 86 (5) ◽  
pp. 725-730 ◽  
Author(s):  
Edwin Y. Chang ◽  
Chien-Hung Chen ◽  
Hongxiu Ji ◽  
Tian-Li Wang ◽  
Kenneth Hung ◽  
...  
Keyword(s):  
Tumor Cell ◽  
Cancer Immunotherapy ◽  
Gm Csf ◽  
Allogeneic Tumor ◽  
Specific Cancer ◽  
Allogeneic Tumor Cell

Specific cancer immunotherapy adjunctive to surgery for advanced gastric cancer: A report of six long term survivors

1978 ◽  
Vol 13 (1) ◽  
pp. 54-60 ◽  
Author(s):  
Yoshinobu Ishikawa ◽  
Matsuro Fukushima ◽  
Seiro Machida ◽  
Hideo Kakuta ◽  
Teiji Nishikawa ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Immunotherapy ◽  
Advanced Gastric Cancer ◽  
Specific Cancer ◽  
Long Term Survivors

Abstract 5018: HLA class I expression in a tumor is higher than that out of a tumor: Promising new findings for antigen-specific cancer immunotherapy

2015 ◽  
Author(s):  
Daisule Nobuoka ◽  
Mari Takahashi ◽  
Toshiaki Yoshikawa ◽  
Takahito Yagi ◽  
Toshiyoshi Fujiwara ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Hla Class I ◽  
Class I ◽  
New Findings ◽  
Specific Cancer

MAGRIT phase III trial: MAGE-A3 antigen-specific cancer immunotherapy (ASCI) as adjuvant therapy in patients with completely resected stage IB-IIIA NSCLC.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. TPS210-TPS210 ◽  
Author(s):  
P. Therasse ◽  
J. F. Vansteenkiste ◽  
M. Zielinski ◽  
T. M. De Pas ◽  
D. Atanackovic ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Cancer Immunotherapy ◽  
Phase Iii ◽  
Phase Iii Trial ◽  
Stage Ib ◽  
Specific Cancer ◽  
Resected Stage ◽  
Iiia Nsclc

Dendritic Cells for Specific Cancer Immunotherapy

2001 ◽  
Vol 382 (4) ◽  
Author(s):  
Norbert Meidenbauer ◽  
Reinhard Andreesen ◽  
Andreas Mackensen
Keyword(s):  
Dendritic Cells ◽  
Cancer Immunotherapy ◽  
Specific Cancer
Sign in / Sign up

Export Citation Format

Share Document